FDA Inspection 984370 — GlaxoSmithKline Research & Development Limited
The FDA completed an inspection of GlaxoSmithKline Research & Development Limited on June 24, 2016 in Stevenage. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- June 24, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Stevenage (United Kingdom)